iRadimed Sees Q2 GAAP EPS $0.40-$0.44 vs $0.42 Est

Benzinga Newsdesk www.benzinga.com Positive 47.4%

Neg 0% Neu 0% Pos 47.4%

iRadimed (NASDAQ:IRMD) is looking for Q2 GAAP EPS of $0.40-$0.44 vs $0.42 analyst estimate..

Comments

No comments yet. Be the first!